Effect of antiviral therapy on the occurrence of hepatitis B-related hepatocellular carcinoma
10.3760/cma.j.issn.1007-3418.2019.09.014
- VernacularTitle: 抗病毒治疗对乙型肝炎相关肝细胞癌发生的影响
- Author:
Jing SUN
1
;
Shan ZHANG
;
Yixuan WANG
;
Lin ZHU
;
Huichun XING
Author Information
1. Department of Hepatology, Division 3, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China
- Publication Type:Review
- Keywords:
Hepatitis B virus;
Hepatocellular carcinoma;
Nucleotide analogues;
Interferon
- From:
Chinese Journal of Hepatology
2019;27(9):721-724
- CountryChina
- Language:Chinese
-
Abstract:
Clinically, hepatocellular carcinoma (HCC) is one of the most common malignant tumors with a high rate of morbidity and mortality. Hepatitis B virus infection is the main cause of hepatocellular carcinoma in China and it is a serious threat to people's health. Antiviral drugs such as nucleos(t)ide analogues and interferon can inhibit viral replication and liver fibrosis progression and reduce the occurrence of hepatitis B-related HCC. This article reviews the effects of different antiviral therapy on the occurrence of hepatitis B-related hepatocellular carcinoma in recent years.
